Plunkett Research Online: LogicBio Therapeutics Inc

LOGICBIO THERAPEUTICS INC (LOGC:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

LogicBio Therapeutics, Inc. is a genome-editing company focused on developing medicines to treat rare diseases in patients with significant unmet medical need. The firm uses GeneRide, its proprietary technology platform designed to precisely integrate corrective genes into a patient’s genome to pro.....



LogicBio Therapeutics Inc
Ticker: LOGC
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617-245-0399
Fax:
Address: 99 Erie Street
Cambridge, MA 02139 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Biological Product (except Diagnostic) Manufacturing
Contacts Description

Frederic Chereau CEO/Director/President
Matthias Jaffe CFO
See More
LogicBio Therapeutics, Inc. is a genome-editing company focused on developing medicines to treat rare diseases in patients with significant unmet medical need. The firm uses GeneRide, its proprietary technology platform designed to precisely integrate corrective genes into a patient’s genome to pro.....See More See More

Auditor: Deloitte & Touche LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
GeneRide
LB-001
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: